Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
Abstract Chimeric antigen receptor-modified T cell therapy, originally employed in hematological malignancies treatment, has made significant strides in addressing solid tumors in recent years. Presently, second-generation CAR-T therapy has reached clinical implementation, while fifth-generation CAR...
Saved in:
| Main Authors: | Jiajun Zhu, Jianming Zhou, Yiting Tang, Ruotong Huang, Chengjia Lu, Ke Qian, Qingyu Zhou, Jingjun Zhang, Xiaoyi Yang, Wenhan Zhou, Jiaqiang Wu, Qiudan Chen, Yong Lin, Shuying Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03938-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
by: Safwaan H. Khan, et al.
Published: (2025-01-01) -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy
by: Bohan Zhang, et al.
Published: (2025-02-01)